INMed’s ShortCut™ GJ Feeding Tube with Rapid Exchange Technology
GJ tube patients are solely reliant on feeding tubes for their nutritional, hydration and medication needs. All GJ feeding tubes have a propensity to clog with normal usage at rates up to 45%.
A clogged GJ feeding tube requires urgent medical attention and a hospital visit to undergo a tube exchange, typically performed by an Interventional Radiologist (IR).
INMed’s “game changing” ShortCut™ GJ feeding tube with an innovative embedded sealed bypass exchange catheter ensures GJ tube replacements are rapid and predictable.
No currently marketed GJ feeding tube allows for the removal and exchange of a clogged tube via a minimally invasive, over-the-wire procedure without giving up gastrointestinal (GI) access.
The predictability of the ShortCut™ GJ tube will reduce patient and IR staff radiation exposure as well as shorten clogged GJ tube replacement procedure times by up to forty-five minutes.
PortIO™ Implantable Intraosseous Vascular Access Device
PAVmed (PAVM – NASDAQ) and Hatch Medical have entered into a joint venture to complete development and commercialization of their PortIO™ Implantable Intraosseous Vascular Access Device.
- Bone marrow provides a “non-collapsible” vein that does not clot.
- Infused fluid reaches central circulation as quickly as traditional intravenous routes.
- IO use to date has been limited to short-term use (up to 48 hours) in narrow applications.
- PortIO is the first implantable, IO vascular access device designed for long-term use.
- PortIO resides completely subcutaneously, analogous to long-term implantable vascular access ports (“port-a-caths”), but without a reservoir.
- Subcutaneous needle access analogous to long-term ports, except needle tip resides in bone marrow cavity not reservoir.
- Completed IRB-approved First-in-Human studies of PortIO in Colombia in 2022, with excellent device function and no complications across nine patients.
AdVENTage® Bone Marrow Aspiration Biopsy System
Developed in conjunction with serial inventor, Alec Goldenberg, M.D. , engineering partner, Paul Hendrixson and the team at Hatch Medical, L.L.C.
AdVENTage® features a patented venting mechanism which reduces negative pressure during aspiration and as a result, potentially reducing patient pain and discomfort.
Bone marrow aspiration biopsies are known to be extremely painful for patients. It is believed that the negative pressure introduced into the bone marrow space during aspiration stimulates a variety of nerve fibers resulting in pain.
The venting feature of AdVENTage® also makes material collection more effective than traditional methods based upon benchtop testing.
AdVENTage® is planned to be available in 15 and 16 gauge sizes for greater clinical and procedural options.
VascuTech Medical Radial Sheath Line
VascuTech Medical and Dr. Jonathan Levine, an interventional radiologist, developed what is arguably the most advanced transradial sheath line available today.
Special Features Include:
- Vapor™ Transition-less Technology
- Thin wall extrusion reduces overall profile and insertion forces
- Proprietary Oculus™ Hemostatic Valve
- 4F, 5F, 6F & 7F configurations
Thermotex Therapy Systems Ltd. – Far Infrared Heat Therapy
We are working to identify private label and distribution partners for Thermotex Therapy Systems’ FDA and Health Canada-registered line of far infrared heat therapy systems.
Clinical studies show that radiant heat generated through proprietary Thermotex technology is absorbed in the body at depths of 2.36 inches (10 times deeper than standard heating pads), promoting increased blood flow through vasodilation, assisting with a reduction in inflammation and delivering an analgesic effect, resulting in pain relief.
Learn more by watching the brief video – Watch the Thermotex video here!